Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximillian A Robinson

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|September 19, 2022
Impact of CTLA-4 checkpoint antibodies on ligand binding and TransendocytosisCayman Williams, Alan Kennedy, Maximillian A Robinson, et al.
The EMBO Journal|February 2, 2023
The CTLA-4 immune checkpoint protein regulates PD-L1:PD-1 interaction via transendocytosis of its ligand CD80Alan Kennedy, Maximillian A Robinson, Claudia Hinze, et al.
Cell Reports|September 15, 2024
Rigid, bivalent CTLA-4 binding to CD80 is required to disrupt the cis CD80/PD-L1 interactionMaximillian A Robinson, Alan Kennedy, Carolina T Orozco, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|September 19, 2022
Impact of CTLA-4 checkpoint antibodies on ligand binding and TransendocytosisCayman Williams, Alan Kennedy, Maximillian A Robinson, et al.
The EMBO Journal|February 2, 2023
The CTLA-4 immune checkpoint protein regulates PD-L1:PD-1 interaction via transendocytosis of its ligand CD80Alan Kennedy, Maximillian A Robinson, Claudia Hinze, et al.
Cell Reports|September 15, 2024
Rigid, bivalent CTLA-4 binding to CD80 is required to disrupt the cis CD80/PD-L1 interactionMaximillian A Robinson, Alan Kennedy, Carolina T Orozco, et al.
Pageof 1